Logo image of CNM

CORE & MAIN INC-CLASS A (CNM) Stock Fundamental Analysis

USA - NYSE:CNM - US21874C1027 - Common Stock

51.25 USD
+0.54 (+1.06%)
Last: 9/23/2025, 8:04:00 PM
51.25 USD
0 (0%)
After Hours: 9/23/2025, 8:04:00 PM
Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to CNM. CNM was compared to 49 industry peers in the Trading Companies & Distributors industry. While CNM has a great profitability rating, there are some minor concerns on its financial health. CNM is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

CNM had positive earnings in the past year.
In the past year CNM had a positive cash flow from operations.
CNM had positive earnings in each of the past 5 years.
Of the past 5 years CNM 4 years had a positive operating cash flow.
CNM Yearly Net Income VS EBIT VS OCF VS FCFCNM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M 1B

1.2 Ratios

With a decent Return On Assets value of 6.83%, CNM is doing good in the industry, outperforming 69.39% of the companies in the same industry.
The Return On Equity of CNM (22.85%) is better than 83.67% of its industry peers.
CNM's Return On Invested Capital of 10.97% is fine compared to the rest of the industry. CNM outperforms 71.43% of its industry peers.
CNM had an Average Return On Invested Capital over the past 3 years of 13.05%. This is above the industry average of 10.06%.
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROIC 10.97%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
CNM Yearly ROA, ROE, ROICCNM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

1.3 Margins

The Profit Margin of CNM (5.57%) is better than 65.31% of its industry peers.
CNM's Profit Margin has improved in the last couple of years.
CNM has a better Operating Margin (9.44%) than 67.35% of its industry peers.
In the last couple of years the Operating Margin of CNM has grown nicely.
With a Gross Margin value of 26.67%, CNM perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
In the last couple of years the Gross Margin of CNM has grown nicely.
Industry RankSector Rank
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
CNM Yearly Profit, Operating, Gross MarginsCNM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 2025 5 10 15 20 25

5

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CNM is still creating some value.
Compared to 1 year ago, CNM has less shares outstanding
CNM has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, CNM has a worse debt to assets ratio.
CNM Yearly Shares OutstandingCNM Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M
CNM Yearly Total Debt VS Total AssetsCNM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B 5B

2.2 Solvency

An Altman-Z score of 3.38 indicates that CNM is not in any danger for bankruptcy at the moment.
CNM has a Altman-Z score (3.38) which is in line with its industry peers.
CNM has a debt to FCF ratio of 4.00. This is a neutral value as CNM would need 4.00 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 4.00, CNM is doing good in the industry, outperforming 67.35% of the companies in the same industry.
A Debt/Equity ratio of 1.18 is on the high side and indicates that CNM has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 1.18, CNM is doing worse than 65.31% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Altman-Z 3.38
ROIC/WACC1.07
WACC10.21%
CNM Yearly LT Debt VS Equity VS FCFCNM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 2025 0 500M 1B 1.5B 2B

2.3 Liquidity

A Current Ratio of 2.25 indicates that CNM has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.25, CNM is in line with its industry, outperforming 57.14% of the companies in the same industry.
A Quick Ratio of 1.30 indicates that CNM should not have too much problems paying its short term obligations.
CNM has a Quick ratio of 1.30. This is comparable to the rest of the industry: CNM outperforms 55.10% of its industry peers.
Industry RankSector Rank
Current Ratio 2.25
Quick Ratio 1.3
CNM Yearly Current Assets VS Current LiabilitesCNM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

6

3. Growth

3.1 Past

CNM shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.43%, which is quite good.
Measured over the past years, CNM shows a very strong growth in Earnings Per Share. The EPS has been growing by 64.38% on average per year.
The Revenue has grown by 11.02% in the past year. This is quite good.
The Revenue has been growing by 17.04% on average over the past years. This is quite good.
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%

3.2 Future

CNM is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 10.23% yearly.
CNM is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 3.74% yearly.
EPS Next Y9.09%
EPS Next 2Y11.84%
EPS Next 3Y10.23%
EPS Next 5YN/A
Revenue Next Year3.03%
Revenue Next 2Y3.8%
Revenue Next 3Y3.74%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
CNM Yearly Revenue VS EstimatesCNM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2B 4B 6B 8B
CNM Yearly EPS VS EstimatesCNM Yearly EPS VS EstimatesYearly EPS VS Estimates 2022 2023 2024 2025 2026 2027 2028 1 2 3

4

4. Valuation

4.1 Price/Earnings Ratio

CNM is valuated rather expensively with a Price/Earnings ratio of 20.18.
CNM's Price/Earnings ratio is a bit cheaper when compared to the industry. CNM is cheaper than 69.39% of the companies in the same industry.
CNM's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.41.
Based on the Price/Forward Earnings ratio of 17.81, the valuation of CNM can be described as rather expensive.
CNM's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CNM is cheaper than 63.27% of the companies in the same industry.
CNM's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.87.
Industry RankSector Rank
PE 20.18
Fwd PE 17.81
CNM Price Earnings VS Forward Price EarningsCNM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

CNM's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNM indicates a somewhat cheap valuation: CNM is cheaper than 77.55% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.94
EV/EBITDA 13.22
CNM Per share dataCNM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20 30

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
CNM has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)2.22
PEG (5Y)0.31
EPS Next 2Y11.84%
EPS Next 3Y10.23%

0

5. Dividend

5.1 Amount

No dividends for CNM!.
Industry RankSector Rank
Dividend Yield N/A

CORE & MAIN INC-CLASS A

NYSE:CNM (9/23/2025, 8:04:00 PM)

After market: 51.25 0 (0%)

51.25

+0.54 (+1.06%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)09-09 2025-09-09/bmo
Earnings (Next)12-02 2025-12-02/bmo
Inst Owners112.46%
Inst Owner Change-1.5%
Ins Owners0.56%
Ins Owner Change7.79%
Market Cap10.12B
Analysts76.67
Price Target60.84 (18.71%)
Short Float %5.49%
Short Ratio4.39
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)7.35%
Min EPS beat(2)5.47%
Max EPS beat(2)9.23%
EPS beat(4)4
Avg EPS beat(4)6.98%
Min EPS beat(4)0.71%
Max EPS beat(4)12.5%
EPS beat(8)7
Avg EPS beat(8)3.71%
EPS beat(12)11
Avg EPS beat(12)5.9%
EPS beat(16)15
Avg EPS beat(16)11.78%
Revenue beat(2)1
Avg Revenue beat(2)-0.19%
Min Revenue beat(2)-3.06%
Max Revenue beat(2)2.69%
Revenue beat(4)3
Avg Revenue beat(4)0.38%
Min Revenue beat(4)-3.06%
Max Revenue beat(4)2.69%
Revenue beat(8)4
Avg Revenue beat(8)-0.64%
Revenue beat(12)5
Avg Revenue beat(12)-0.44%
Revenue beat(16)9
Avg Revenue beat(16)2.34%
PT rev (1m)-8.14%
PT rev (3m)-5.41%
EPS NQ rev (1m)-1.66%
EPS NQ rev (3m)-0.77%
EPS NY rev (1m)0%
EPS NY rev (3m)1.04%
Revenue NQ rev (1m)-1.41%
Revenue NQ rev (3m)-2.41%
Revenue NY rev (1m)-1.54%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 20.18
Fwd PE 17.81
P/S 1.31
P/FCF 17.94
P/OCF 16.7
P/B 5.36
P/tB N/A
EV/EBITDA 13.22
EPS(TTM)2.54
EY4.96%
EPS(NY)2.88
Fwd EY5.61%
FCF(TTM)2.86
FCFY5.57%
OCF(TTM)3.07
OCFY5.99%
SpS39.2
BVpS9.55
TBVpS-4.45
PEG (NY)2.22
PEG (5Y)0.31
Profitability
Industry RankSector Rank
ROA 6.83%
ROE 22.85%
ROCE 14.09%
ROIC 10.97%
ROICexc 11.03%
ROICexgc 23.74%
OM 9.44%
PM (TTM) 5.57%
GM 26.67%
FCFM 7.29%
ROA(3y)7.26%
ROA(5y)5.33%
ROE(3y)23.57%
ROE(5y)17.76%
ROIC(3y)13.05%
ROIC(5y)10.52%
ROICexc(3y)13.27%
ROICexc(5y)10.76%
ROICexgc(3y)30.58%
ROICexgc(5y)28.28%
ROCE(3y)16.76%
ROCE(5y)13.51%
ROICexcg growth 3Y-1.87%
ROICexcg growth 5Y6.48%
ROICexc growth 3Y6.77%
ROICexc growth 5Y19.1%
OM growth 3Y4.39%
OM growth 5Y16.07%
PM growth 3Y18.52%
PM growth 5Y35.35%
GM growth 3Y1.32%
GM growth 5Y2.7%
F-Score6
Asset Turnover1.23
Health
Industry RankSector Rank
Debt/Equity 1.18
Debt/FCF 4
Debt/EBITDA 2.41
Cap/Depr 21.54%
Cap/Sales 0.54%
Interest Coverage 4.84
Cash Conversion 65.44%
Profit Quality 130.86%
Current Ratio 2.25
Quick Ratio 1.3
Altman-Z 3.38
F-Score6
WACC10.21%
ROIC/WACC1.07
Cap/Depr(3y)20.09%
Cap/Depr(5y)16.28%
Cap/Sales(3y)0.48%
Cap/Sales(5y)0.43%
Profit Quality(3y)174.31%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.43%
EPS 3Y44.94%
EPS 5Y64.38%
EPS Q2Q%29.85%
EPS Next Y9.09%
EPS Next 2Y11.84%
EPS Next 3Y10.23%
EPS Next 5YN/A
Revenue 1Y (TTM)11.02%
Revenue growth 3Y14.14%
Revenue growth 5Y17.04%
Sales Q2Q%6.57%
Revenue Next Year3.03%
Revenue Next 2Y3.8%
Revenue Next 3Y3.74%
Revenue Next 5YN/A
EBIT growth 1Y3.25%
EBIT growth 3Y19.16%
EBIT growth 5Y35.85%
EBIT Next Year34.31%
EBIT Next 3Y16.22%
EBIT Next 5YN/A
FCF growth 1Y-32.7%
FCF growth 3YN/A
FCF growth 5Y24.92%
OCF growth 1Y-29.78%
OCF growth 3YN/A
OCF growth 5Y24.63%